1.Vandenplas Y, Rudolph CD: Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). Journal of Pediatric Gastroenterology and Nutrition 2009, 49:498–547.
2.Rosen R, Vandernplas Y, Singenedonk M, Cabana M, DiLorenzo C, Gottrand F, Gupta S, Langendam M, Staiano A, Thapar N et al: Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastoenterolgy and Nutrition 2018, 66(3).
3.Czinn SJ, Blanchard S: Gastroesophageal Reflux Disease in Neonates and Infants: When and How to Treat Paediatr Drugs 2013, 15(1):19–25.
4.Davies L, Burman-Roy S, Murphy SM: Gastro-oesophageal reflux disease in children and young people: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people. The British Medical Journal 2015, 350(g7703).
5.Hegar B, Dewanti NR, Kadim M, Alatas S, Firmansyah A, Vandenplas Y: Natural evolution of regurgitation in healthy infants. Acta Paediatrica 2009, 98(7):1189–1193.
6.Baird DC, Harker DJ, Karmes AS, Darnall CR: Diagnosis and Treatment of Gastroesophageal Reflux in Infants and Children. American Family Physician 2015, 92(8):705–717.
7.Campanozzi A, Boccia G, Pensabene L, Panetta G, Marseglia A, Strisciuglio P, Barbera C, Magazzu G, Pettoello-Mantovani M, Staiano A: Prevalence and Natural History of Gastroesophageal Reflux: Pediatric Prospective Survey. Pediatrics 2009, 123:779–783.
8.Martin M, Pratt N, Kennedy D, Ryan P, Ruffin R, Miles H, J M: Natural history and familial relationships of infant spilling to 9 years of age. . Pediatrics 2002, 109(6):1061–1067.
9.The Royal Children’s Hospital Melbourne: Clinical practice guidelines: gastro-oesophageal reflux in infants. . In.; 2010.
10.Fike FB, Mortellaro VE, Pettiford J, Ostlie DJ, St.Peter SD: Diagnosis of gastroesophageal reflux disease in infants. . Pediatric Surgical International 2011, 27:791–979.
11.Dranove JE: Focus on diagnosis: new technologies for the diagnosis of gastroesophageal reflux disease. Pediatric Review 2008, 29:317–320.
12.Omari T,.IMiki K, Davidson G, Fraser R, Haslam R, Goldsworthy W, Bakewell M, Dent J: Characterisation of relaxation of the lower oesophageal sphincter in healthy premature infants. . Gut 1997, 40:370–375.
13.Psaila K, Foster J: Critically Ill Infants with Gastro-Oesophageal Reflux. In: diet and Nutrition in Critical Care. Volume 1, edn. Edited by Rajendram R, Preedy VR, Patel VB. New York: Springer; 2015: 859–870.
14.Lightdale JR, Gremse DA: Section on Gastroenterology, Hepatology and Nutrition. Gastroesophageal relux: management guidance for the pediatrician. Pediatrics 2013, 131:e1684–1695.
15.Bell JC, Schneuer FJ, Harrison C, Trevena L, Hiscock H, Eshaug G, Nassar N: Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey Archives of Disease in Childhood 2018, 103(7):660–664.
16.Dahlen HG, Foster JP, Psaila K, Spence K, Badawi N, Fowler C, Schmied V, Thornton C: Gastro-oesophageal reflux: a mixed methods study of infants admitted to hospital in the first 12 months following birth in NSW (2000–2011),. BMC Pediatr 2018, 18(30).
17.Kirby CN, Segal AY, Hinds R, Jones KM, Piterman L: Infant gastro-oesophageal reflux disease (GORD):Australian GP attitudes and practices. Journal Paediatric Child Health 2016, 52:47–53.
18.Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S et al: Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. . Nat Rev Gastroenterol Hepatol 2014, 11:506–514.
19.Hemaiswarya S, Raja R, Ravikumar R, Carvalho IS: Mechanism of Action of Probiotics. Brazilian ARchives of Biology and Technology 2013, 56(1):113–119.
20.Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A: Probiotic Mechanisms of Action. Annales of Nutrition Metabolism 2012, 61(160–174).
21.Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R: Current understanding of the human microbiome. Nat Med 2018, 24(4):392–400.
22.Gogineri A, Caunt M, Crow A, Lee CV, Fuh G, van Bruggen N, Ye W, Weimer RM: Inhibition of VEGF-C Modulates Distal Lymphatic Remodeling and Secondary Metastasis. PloS ONE 2013.
23.Walker AW: Mechanisms of action of probiotics. Clin Infect Dis 2008, 46(Issue Supplement_2):S87-S91.
24.Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Chari RS, Sears MR, Becker AB, Scott JA, Kozyrskyj AL: Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. . Can Med Assoc J 2013.
25.Hyde MJ, Mostyn A, Modi N, Kemp PR: The health implications of birth by caesarean section. . Biol Rev 2012, 87(1):229–243.
26.Indrio F, Di Mauro A, Riezzo G, Civardi E, Intini C, Corvaglia L, Ballardini E, Bisceglia M, Cinquetti M, Brazzoduro E et al: Prophylactic use of probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. . JAMA Pediatrics 2014, 168(3):228–233.
27.Di Mauro A, Neu J, Riezzo G, Raimondi R, Martinelli D, Francavilla R, Indrio F: Gastrointestinal function development and microbiota. . Ital J Pediatr 2013, 39(15):1–7.
28.Indrio F, Riezzo G, Raimondi F, Bisceglia M, Filannino A, Cavallo L, Francavilla R: Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. Eur J Clin Invest 2011, 41(4):417–422.
29.AlFaleh K, Anabrees J: Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews 2014, CD005496(4).
30.Anabrees J, Indrio F, Paes B, Al Faleh K: Probiotics for infantile colic: a systematic review. . BMC Pediatr 2013, 13(186).
31.Chau K, Lau E, Greenberg S, Jacobson S, Yazdani-Brojeni P, Verma N, Koren G: Probiotics for Infantile Colic: A Randomized, Double-Blind, Placebo-Controlled Trial Investigating Lactobacillus reuteri DSM 17938. . Journal of Pediatrics 2015, 166:74–78.
32.Goldenberg JZ, Yap C, Lytvyn L, Lo CKF, Beardsley J, Mertz D, Johnston BC: Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews 2017, CD006095(12).
33.Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P: A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 2009, 9(15).
34.Newlove-Delgado TV, Martin AE, Abbott RA, Bethe lA, Thompson-Coon J, Whear R, Logan S: Dietary interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews 2017, CD010972.(3).
35.Allen SJ, Martinez EG, Gregorio GV, Dans LF: Probiotics for treating acute infectious diarrhoea. Cochrane Database of Systematic Reviews 2010, CD003048(11).
36.Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, Roos S, Matteuzzi D: Lactobacillus reuteri DSM 17938 in Infantile Colic: A Randomized, Double-Blind, Placebo-Controlled Trial. . Pediatrics 2010, 126:e526-e533.
37.Sung V, Collett S, de Gooyer T, Hiscock H, Tang M, Wake M: Probiotics to Prevent or Treat Excessive Infant Crying Systematic Review and Meta-analysis. JAMA Pediatrics 2013, 167(12):1150–1157.
38.Sung V, Hiscock H, Tang M, Mensah FK, Nation ML, Satzke C, Heine RG, Stock A, Barr RG, Wake M: Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. . British Medical Journal 2014, 348(g2107).
39.Szajewska H, Gyrczuk E, Horvath A: Lactobacillus reuteri DSM 17938 for the Management of Infantile Colic in Breastfed Infants: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Pediatrics 2013, 162(257–262).
40.Allen M, MacLeod T, Handfield-Jones R, Sinclair D, Fleming M: Presentation of evidence in continuing medical education programs: a mixed methods study. Journal of Continuing Education in the Health Professions 2010, 30(4):221–228.
41.Baldassarre ME, Di Mauro A, Mastromarino P, Fanelli M, Martinelli D, Urbano F, Capobianco D, Laforgia N: Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial. Nutrients 2016, 8(11).
42.Higgins JPT, Green S: Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. . In. Edited by Collaboration TC; 2011.
43.Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R: The Effects of Probiotics on Feeding Tolerance, Bowel Habits,and Gastrointestinal Motility in Preterm Newborns. Journal of Pediatrics 2008, 152:801–806.
44.Indrio F, Riezzo G, Tafuri S, Ficarella M, Carlucci B, Bisceglia M, Polimeno L, Francavilla R: Probiotic Supplementation in Preterm: Feeding Intolerance and Hospital Cost. Nutrients 2017, 9(9).
45.Garofoli F, Civardi E, Indrio F, Mazzucchelli I, angelini M, Tinelli C, Stronati M: The early administration of Lactobacillus reuteri DSM 17938 controls regurgitation episodes in fullterm breastfed infants. Int J Food Sci Nutr 2014, 65(5):646–648.
46.Garofoki F, Civardi E, Indrio F, Mazzucchelli I, Micol A, Tinelli C, Stronati M: The early administration of Lactobacillus reuteri DSM 17938 controls regurgitation episodes in fullterm breastfed infants. Journal of Food Sciences and Nutrition 2014, 65(5):646–648.
47.Wang Z, Chai L, Yang Z, Wang Y, Wang H: Identifying sources and assessing potential risk of heavy metals in soils from direct exposure to children in a mine-impacted city, Changsha, China. J Environ Qual 2010, 39(5):1616–1623.
48.Collins SM, Bercik P: The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009, 136(6):2003–2014.
49.Priddis H, Thornton C, Fowler C, Schmied V, Tooher J, Dickenson M, Dahlen HG: Characteristics and service needs of women and babies admitted to residential parenting units in New South Wales: A mixed‐methods study. Journal of Clinical Nursing 2018, |https://doi.org/10.1111/jocn.14497.
50.Urbańska M, Szajewska H: The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. European Journal of Pediatrics 2014, 173(10):1327–1337.
51.Talarico TL, Casas IA, Chung TC, Dobrogosz WJ: Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimcrobial Agents Chemotherapy 1988, 32(12):1854–1858.
52.Axelsson LT, Chung TC, Dobrogosz WJ, Lindgren SE: Production of a Broad Spectrum Antimicrobial Substance by Lactobacillus reuteri. Microb Ecol Health Dis 1989, 2(2):131–136.
53.Lin PW, Nasr TR, Berardinelli AJ, Kumar A, Neish AS: The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut. Pediatr Res 2008, 64:511–516.
54.Liu Y, Fatheree NY, Mangalat N, Rhoads JM: Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. American Journal of Physiology-Gastrointestinal Live Physiology 2010, 299(5):1087–1096.